A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Direxion Daily Healthcare Bull stock. As of the latest transaction made, Citadel Advisors LLC holds 8,800 shares of CURE stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,800
Previous 14,300 38.46%
Holding current value
$1.02 Million
Previous $1.79 Million 42.72%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$102.21 - $122.25 $242,442 - $289,977
2,372 Added 6.33%
39,828 $4.65 Million
Q1 2024

May 15, 2024

BUY
$105.2 - $126.4 $37,240 - $44,745
354 Added 0.95%
37,456 $4.7 Million
Q4 2023

Feb 14, 2024

SELL
$76.46 - $101.74 $434,369 - $577,984
-5,681 Reduced 13.28%
37,102 $3.77 Million
Q3 2023

Nov 14, 2023

BUY
$88.53 - $107.13 $1.33 Million - $1.61 Million
15,042 Added 54.22%
42,783 $3.79 Million
Q2 2023

Aug 14, 2023

BUY
$87.79 - $109.66 $643,412 - $803,698
7,329 Added 35.91%
27,741 $2.77 Million
Q1 2023

May 15, 2023

BUY
$85.05 - $114.38 $1.53 Million - $2.05 Million
17,947 Added 728.07%
20,412 $1.96 Million
Q4 2022

Feb 14, 2023

BUY
$85.14 - $125.74 $209,870 - $309,949
2,465 New
2,465 $282,000
Q1 2022

May 16, 2022

BUY
$103.7 - $140.41 $61,805 - $83,684
596 Added 20.61%
3,488 $455,000
Q4 2021

Feb 14, 2022

SELL
$102.43 - $146.64 $350,208 - $501,362
-3,419 Reduced 54.18%
2,892 $419,000
Q3 2021

Nov 15, 2021

BUY
$107.32 - $132.84 $368,966 - $456,703
3,438 Added 119.67%
6,311 $678,000
Q1 2021

May 17, 2021

SELL
$70.75 - $87.68 $38,558 - $47,785
-545 Reduced 15.94%
2,873 $240,000
Q4 2020

Feb 16, 2021

SELL
$55.71 - $77.02 $31,866 - $44,055
-572 Reduced 14.34%
3,418 $263,000
Q3 2020

Nov 16, 2020

SELL
$55.32 - $70.22 $2.41 Million - $3.06 Million
-43,556 Reduced 91.61%
3,990 $252,000
Q2 2020

Aug 14, 2020

SELL
$35.24 - $61.25 $1.59 Million - $2.77 Million
-45,241 Reduced 48.76%
47,546 $2.58 Million
Q1 2020

May 15, 2020

SELL
$24.59 - $79.8 $671,085 - $2.18 Million
-27,291 Reduced 22.73%
92,787 $3.7 Million
Q4 2019

Feb 14, 2020

SELL
$46.92 - $75.03 $2.13 Million - $3.41 Million
-45,462 Reduced 27.46%
120,078 $8.85 Million
Q3 2019

Nov 14, 2019

SELL
$48.43 - $59.37 $378,189 - $463,620
-7,809 Reduced 4.5%
165,540 $8.37 Million
Q2 2019

Aug 14, 2019

BUY
$45.11 - $58.29 $1.4 Million - $1.81 Million
30,999 Added 21.78%
173,349 $9.73 Million
Q1 2019

May 15, 2019

BUY
$42.66 - $57.9 $1.42 Million - $1.92 Million
33,238 Added 30.46%
142,350 $0
Q4 2018

Feb 14, 2019

BUY
$39.11 - $67.75 $393,603 - $681,836
10,064 Added 10.16%
109,112 $5.19 Million
Q3 2018

Nov 13, 2018

BUY
$45.79 - $66.62 $942,220 - $1.37 Million
20,577 Added 26.22%
99,048 $0
Q2 2018

Aug 10, 2018

BUY
$40.07 - $49.09 $1.38 Million - $1.69 Million
34,505 Added 78.48%
78,471 $0
Q1 2018

May 11, 2018

BUY
$40.52 - $62.95 $1.26 Million - $1.96 Million
31,187 Added 244.05%
43,966 $1.89 Million
Q4 2017

Feb 09, 2018

BUY
$43.42 - $48.88 $282,230 - $317,720
6,500 Added 103.52%
12,779 $596,000
Q3 2017

Nov 09, 2017

BUY
$44.53 - $45.49 $279,603 - $285,631
6,279
6,279 $286,000

Others Institutions Holding CURE

About DIREXION DAILY HEALTHCARE BULL


  • Ticker CURE
  • Sector ETFs
  • Industry ETFs
More about CURE
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.